
Yakult Honsha Co.,Ltd.
YKLTY
Updated: 24/09/2026, 04:29:23
Founded in Tokyo, Japan, in 1935, Yakult Honsha Co., Ltd. is a diversified corporation engaged in the creation and sale of a broad spectrum of goods. Its principal activities span food and beverage items, beauty products, and pharmaceutical drugs. The company's extensive food and beverage division operates across several global territories, including Japan, the Americas, Asia and Oceania, and Europe. This segment provides various offerings such as fermented milk beverages, juices, and noodles, which are distributed to consumers through both direct-to-home delivery services and conventional retail outlets. Within its pharmaceutical operations, Yakult Honsha focuses on developing and commercializing specialized medicines. These include the anti-cancer medication Elplat, along with generic versions of anti-tumor agents like Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Beyond these core areas, Yakult Honsha also participates in the cosmetics sector and notably owns a professional sports franchise, the Tokyo Yakult Swallows baseball team.
No summaries found.
- Share price
- $8.00
- Market cap
- $4.60B
- Exchange
- OTC
- Currency
- USD
- CEO
- Hiroshi Natsume
- Employees
- 29,618
- IPO date
- 13/09/2013
- Beta
- 0.078
- Last dividend
- $0.00
- Day range
- $8.00 – $8.00
- 52-week range
- $7.02 – $10.34
- 1-day performance
- -9.19%
- 1-year performance
- 13.96%
- Current drawdown (1Y)
- -22.63%
- CIK
- 0001538118
- CUSIP
- 984541102
- ISIN
- US9845411027
- Created
- 07/12/2025, 15:12:34
- Last update
- 24/09/2026, 04:29:23
Track Yakult Honsha Co.,Ltd. with an AI analyst
See which prediction-market events move YKLTY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.